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I. General Experimental Details 
Unless otherwise noted, all reactions were conducted in flame-dried or oven-dried (120 
°C) sealed tubes with magnetic stirring sealed in a nitrogen glovebox. Solvents were purified 
under nitrogen using a solvent purification system (Innovative Technology, Inc. Model # SPS-
400-3 and PS-400-3). All liquid amines were distilled over calcium hydride before use and 
stored under nitrogen and solid amines were used without further purification, morpholine 
(Sigma-Aldrich), N-methylbutylamine (Sigma-Aldrich), dibutylamine (Sigma-Aldrich), 2-
methylpiperdine (Sigma-Aldrich), 2,6-dimethylpiperdine, predominantly cis (Alfa Aesar), 1-
methylpiperazine (Sigma-Aldrich), N-methylbenzylamine (Sigma-Aldrich), N-methylaniline 
(Sigma-Aldrich), 2,4,6-trimethylaniline (Oakwood Chemicals), 2,6-diisopropylaniline (Oakwood 
Chemicals), aniline (Sigma-Aldrich), octylamine (Sigma-Aldrich), sec-butylamine (Sigma-
Aldrich), iso-butylamine (Sigma-Aldrich), cyclohexylamine (Sigma-Aldrich), 1-adamantylamine 
(Oakwood Chemicals), butylamine (Sigma-Aldrich), benzylamine (Sigma-Aldrich), pyrrolidine 
(Sigma-Aldrich), piperazine (Sigma-Aldrich), 2-(piperazin-1-yl)pyrimidine (Oakwood Chemicals).  
Anhydrous Ni(acac)2 (Strem Chemicals), Ni(COD)2 (Strem Chemicals), IPrMe·HCl (made from 
known procedure1), IMesMe·HCl (made from known procedure1), ICy·HCl (Sigma-Aldrich), 
IAd·HCl (Sigma-Aldrich), IPrCl·HCl (made from known procedure2), IPr·HCl (made from known 
procedure3), IMes·HCl (made from known procedure3), IPr*OMe·HCl (made from known 
procedure4), and NaO-t-Bu (Strem Chemicals) were stored and weighed in an inert atmosphere 
glovebox.  
Analytical thin layer chromatography (TLC) was performed on Kieselgel 60 F254 (250 
μm silica gel) glass plates and compounds were visualized with UV light and p-anisaldehyde, 
potassium permanganate or ceric ammonium molybdate stains. Flash column chromatography 
was performed using Kieselgel 60 (230-400 mesh) silica gel. Eluent mixtures are reported as v:v 
percentages of the minor constituent in the major constituent. All compounds purified by column 
chromatography were sufficiently pure for use in further experiments unless otherwise indicated. 
1H NMR spectra were collected at 400 MHz on a Varian MR400, at 500 MHz on a Varian 
Inova 500 or Varian vnmrs 500, or at 700 MHz on a Varian vnmrs 700 instrument. The proton 
signal of the residual, nondeuterated solvent (δ 7.26 for CHCl3 or 7.15 for C6D6) was used as 
the internal reference for 1H NMR spectra. 13C NMR spectra were completely heterodecoupled 
and measured at 125 MHz or 175 MHz. Chloroform-d (δ 77.00), dimethylsulfoxide-d6 (δ 39.95), 
or benzene-d6 (δ 128.0) was used as an internal reference. High resolution mass spectra were 
recorded on a VG 70-250-s spectrometer manufactured by Micromass Corp. (Manchester UK) 
at the University of Michigan Mass Spectrometry Laboratory. GCMS analysis was carried out on 
a HP 6980 Series GC system with HP-5MS column (30 m x 0.250 mm x 0.25 μm). GCFID 
analysis was carried out on a HP 6980N Series GC system with a HP-5 column (30 m x 0.32 















II. General Procedures 
General Procedure for the synthesis of silyloxyarenes (A): 
 
In a round bottom flask, aryl alcohol (1 equiv.) was dissolved in DMF or CH2Cl2 (5.0 mL). The 
solution was then charged with imidazole (2 equiv.) and tert-butyldimethylchlorosilane (1.5 
equiv.) and stirred until the starting alcohol was fully consumed. The reaction was diluted with 
25 mL Et2O, washed with deionized H2O (3 × 25 mL), dried over MgSO4, filtered, concentrated 
under reduced pressure and purified by flash column chromatography on silica gel to afford the 
aryl silyl ether. 
 
General Procedure for the Ni(COD)2/IPrMe·HCl promoted amination of silyloxyarenes 
using amines (B): 
 
A reaction tube containing a stir bar was charged with aryl silyl ether (1 equiv.), Ni(COD)2 (5 
mol%), IPrMe·HCl  (10 mol%), NaO-t-Bu (2.5 equiv.), toluene (0.5 M) and amine (1.5 equiv.). The 
sealed reaction tube was brought outside the glovebox and placed in a heated block set to 120 
°C and stirred for 16 hours, unless noted otherwise. The mixture was cooled to room 
temperature, quenched with dichloromethane (1 mL), and diluted with EtOAc (3 mL). The 
mixture was then run through a silica plug, concentrated under reduced pressure and purified by 
































III. Supplementary Tables 
 
Table S1. Summary of optimization of nickel-catalyzed amination of silyloxyarenes with 
morpholine. 
 
Discussion for optimization of silyloxyarene amination: Using model substrate, ([1,1'-
biphenyl]-4-yloxy)(tert-butyl)dimethylsilane, and morpholine, ligands previously utilized in the 
activation of aryl methyl ethers, such as PCy3, ICy, or IAd were tested (Table S1, entries 1-3); 
-S5- 
 
however, each resulted in no product. Additionally, small N-aryl NHC ligands such as IMes or 
IMesMe (Table S1, entries 4-5) also showed no evidence of product formation. However, when 
using bulky, aryl NHC ligands, such as IPr derivatives, there appeared to be a strong dependence 
on the electronic influence of the ligand. Placing electron-withdrawing substituents on the 
backbone, like IPrCl (Table S1, entry 6), resulted in low yields, whereas, electron-donating 
substituents, such as IPrMe (Table S1, entries 8), resulted in high yields. Increasing size of the 
NHC ligand further to IPr*OMe, which has previously been demonstrated as a competent ligand 
in the C-O bond activation of silyloxyarenes, resulted in trace product formation (Table S1, entry 
9). Exploring the use of other silyloxyarene derivatives showed a dependence on size and 
electronics of the silane protecting group, with TBS being optimal. High yields were still obtained 
with TBDPS (Table S1, entry 10), although lower yields were obtained with TIPS and TES (Table 
S1, entries 11-12). Other common aryl electrophiles resulted in inferior results with OMe only 
showing trace product and other phenol-derived electrophiles, including OPh, OPiv, and OTf 
(Table S1, entries 14-16), resulting in decreased yields. Additionally, aryl halides (Br, F) resulted 
in low yields, due to conversion of the aryl halide to biphenyl through reduction with the amine 
(see tables S2 and S3 below for more complete optimization). THF and dioxane are also suitable 


















































































IV. Starting Material Synthesis 
 
 







Following general procedure A, [1,1'-biphenyl]-4-ol (851 mg, 5 mmol), imidazole (681 mg, 10 
mmol), tert-butyldimethylsilyl chloride (1.13 g, 7.5 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate = 99:1) to afford the desired product 
as a white solid (1.30 g, 4.57 mmol, 91% yield). The spectral data matches that previously 
reported in the literature.5  
  
1H-NMR (500 MHz, CDCl3): δ 7.55 (dd, J = 8.3, 1.2 Hz, 2H), 7.46 (dt, J = 8.5, 1.9 Hz, 2 H), 7.41 








Following general procedure A, naphthalen-1-ol (1.44 g, 10 mmol), imidazole (1.36 g, 20 mmol), 
and tert-butyldimethylsilyl chloride (2.26 g, 15 mmol) gave a crude mixture which was purified by 
flash chromatography (hexanes: ethyl acetate 99:1) to afford the desired product as a colorless 
oil (1.87 g, 7.24 mmol, 72% yield). The spectral data matches that previously reported in the 
literature.6 
 
1H-NMR (500 MHz, CDCl3): δ 8.20 (m, 1H), 7,80 (m, 1H), 7.46 (m, 3H), 7.33 (t, J = 8.0 Hz, 1H), 







Following general procedure A, naphthalen-2-ol (720.5 mg, 5 mmol), imidazole (681 mg, 10 
mmol), tert-butyldimethylsilyl chloride (1.13 g, 7.5 mmol) gave a crude residue which was 
-S9- 
 
purified by flash chromatography (hexanes: ethyl acetate = 99:1) to afford the desired product 
as a colorless oil (1.23 g, 4.76 mmol, 95% yield. The spectral data matches that previously 
reported in the literature.7 
 
1H-NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 8.8, 1H), 7.69 (d, J = 8.3 Hz, 
1H), 7.42 (dt, J = 7.8, 1.2 Hz, 1H), 7.33 (dt, J = 6.8, 1.2, 1H), 7.19 (d, J = 2.2, 1H), 7.08 (dd, J = 







Following general procedure A, [1,1':4',1''-terphenyl]-2'-ol (931 mg, 5 mmol), imidazole (1.36 g, 
20 mmol), tert-butyldimethylsilyl chloride (2.26 g, 15 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 99:1) to afford the desired product as 
a colorless oil (1.04 g, 2.89 mmol, 58% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.48 (d, J = 8.0 Hz, 2H), 7.37 (t, J = 8.0 Hz, 2H), 7.29 (t, J = 7.5 
Hz, 1H), 6.81 (d, J = 3.0 Hz, 1H), 6.77 (d, J = 8.5 Hz, 1H), 6.69 (dd, J = 8.5, 3.0 Hz, 1H), 0.99 
(s, 9H), 0.81 (s, 9H), 0.19 (s, 6H), -0.12 (s, 9H).   
13C-NMR (125 MHz, CDCl3): δ 149.8, 146.7, 139.1, 133.9, 129.8, 127.8, 126.37, 121.9, 120.9, 
119.3, 25.7, 25.6, 18.2, 18.0, -4.5, -4.7.  
IR (film, cm-1): 2955, 2929, 2885, 2957, 1600, 1445, 1390. 







Following general procedure A, 2-methylquinolin-6-ol (435 mg, 2.73 mmol), imidazole (340 mg, 
5 mmol), tert-butyldimethylsilyl chloride (565 g, 3.75 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the desired product as 
a white solid. (682 mg, 2.5 mmol, 91% yield). The spectral data matches that previously 
reported in the literature.8 
 
1H-NMR (500 MHz, CDCl3): δ 7.89 (d, J = 8.5 Hz, 2H), 7.26 (m, 1H), 7.22 (dd, J = 8.5, 1.0 Hz, 









Following general procedure A, quinolin-3-ol (1.40 g, 9.64 mmol), imidazole (1.36 g, 20 mmol), 
tert-butyldimethylsilyl chloride (2.26 g, 15 mmol) gave a crude residue which was purified by 
flash chromatography (hexanes: ethyl acetate 95:5) to afford the desired product as a colorless 
oil (1.89 g, 7.29 mmol, 76% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 8.60 (d, J = 3.0 Hz, 1H), 7.69 (d, J = 8.0 Hz, 1H), 7.57 (t, J = 8.0 
Hz, 1H), 7.49 (t, J = 8.0 Hz, 1H), 7.44 (d, J = 3.0 Hz, 1H), 1.03 (s, 9H), 0.28 (s, 6H).  
13C-NMR (125 MHz, CDCl3): δ 149.2, 147.0, 143.9, 129.1, 129.0, 137.0, 126.9, 126.7, 121.4, 
25.6, 18.2, -4.4.  
IR (film, cm-1): 2954, 2929, 2858, 1600, 1464, 1416. 







Following general procedure A, [1,1'-biphenyl]-3-ol (1.69 g, 9.93 mmol), imidazole (1.36 g, 20 
mmol), tert-butyldimethylsilyl chloride (2.26 g, 15 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 99:1) to afford the desired product as 
a colorless oil (1.67 g, 5.87 mmol, 59% yield). 
 
1H-NMR (500 MHz, CDCl3): δ 7.58 (d, J = 8.0 Hz, 2H), 7.45 (t, J = 7.5 Hz, 2H), 7.36 (t, J = 7.5 
Hz, 1H), 7.31 (t, J = 8.0 Hz, 1H), 7.21 (d, J = 7.5 Hz, 1H), 6.84 (d, J = 8.0 Hz, 1H), 1.03 (s, 9H), 
0.25 (s, 6H).  
13C-NMR (125 MHz, CDCl3): δ 156.0, 142.7, 141.0, 129.6, 128.7, 127.3, 127.1, 120.2, 118.93, 
118.90, 25.7, 18.2, -4.4. 
IR (film, cm-1): 3063, 2955, 2929, 2857, 1596, 1572, 1476, 1416. 







Following general procedure A, 3-morpholinophenol (445 mg, 2.5 mmol), imidazole (340 mg, 5 
mmol), tert-butyldimethylsilyl chloride (565 g, 3.75 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the desired product as 
a colorless oil (694 mg, 2.36 mmol, 95% yield). The spectral data matches that previously 




1H-NMR (500 MHz, CDCl3): δ 7.11 (t, J = 8.0 Hz, 1H), 6.53 (dd, J = 8.1, 1.8 Hz, 1H), 6.39 








Following general procedure A, N-(4-hydroxyphenyl)acetamide (755 mg, 5 mmol), imidazole 
(681 mg, 10 mmol), tert-butyldimethylsilyl chloride (1.13 g, 7.5 mmol) gave a crude residue 
which was purified by flash chromatography (hexanes: ethyl acetate 80:20) to afford the desired 
product as a white solid (1.18 g, 4.45 mmol, 89% yield). The spectral data matches that 
previously reported in the literature.9 
 
1H-NMR (500 MHz, CDCl3): δ 7.34 (d, J = 8.8 Hz, 2H), 7.02 (bs, 1H), 6.80 (d, J = 8.8 Hz, 2H), 







Following general procedure A, 5,6,7,8-tetrahydronaphthalen-2-ol (741 mg, 5 mmol), imidazole 
(681 mg, 10 mmol), tert-butyldimethylsilyl chloride (1.13 g, 7.5 mmol) gave a crude residue 
which was purified by flash chromatography (hexanes: ethyl acetate 99:1) to afford the desired 
product as a colorless oil (1.26 g, 4.80 mmol, 96% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 6.90 (d, J = 8.5 Hz, 1H), 6.58 (dd, J = 8.0, 2.5 Hz, 1H), 6.54 (d, J 
= 2.5 Hz, 1H), 2.69 (m, 4H), 1.78 (m, 4H), 1.0 (s, 9H), 0.20 (s, 6H). 
13C-NMR (125 MHz, CDCl3): δ 153.1, 138.1, 129.7, 120.1, 117.3, 29.5, 28.6, 25.7, 23.4, 23.1, 
18.2, -4.4. 
IR (film, cm-1): 2928, 2856, 1609, 1498, 1253. 










Following a modified general procedure A (doubling the amount of imidazole and tert-
butyldimethylsilyl chloride), (8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-
decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol (272 mg, 1 mmol), imidazole (272 mg, 4 
mmol), tert-butyldimethylsilyl chloride (578 mg, 3 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 98:2) to afford the desired product as 
a white solid (468 mg, 0.93 mmol, 93% yield). The spectral data matches that previously 
reported in the literature.10 
 
1H-NMR (500 MHz, CDCl3): δ 7.13 (d, J = 8.6 Hz, 1H), 6.62 (dd, J = 8.3, 2.2 Hz, 1H), 6.56 (s, 
1H), 3.65 (t, J = 8.3 Hz, 1H), 2.80 (m, 2H), 2.27 (dd, J = 13.7, 3.2 Hz, 1H), 2.18 (dt, J = 11.5, 3.7 
Hz, 1H), 1.90 – 1.86 (m, 3H), 1.66 (dq, J = 12.0, 3.4 Hz, 1H), 1.54 – 1.27 (m, 7H), 0.99 (s, 9H), 

















































Following general procedure A, 6-bromonaphthalen-2-ol (1.11 g, 5 mmol), imidazole (681 mg, 
10 mmol), and tert-butyldimethylsilyl chloride (1.13 g, 7.5 mmol) gave a crude mixture which 
was purified by flash chromatography (hexanes: ethyl acetate 98:2) to afford the desired product 
as a white solid (1.25 g, 3.70 mmol, 74% yield). The spectral data matches that previously 
reported in the literature.11 
  
1H-NMR (500 MHz, CDCl3): δ 7.92 (s, 1H), 7.63 (d, J = 9.0 Hz, 1H), 7.56 (d, J = 9.0 Hz, 1H), 
7.48 (dd, J = 9.0 Hz, 2.0 Hz, 1H), 7.15 (d, J = 2.5 Hz, 1H), 7.09 (dd, J = 9.0, 2.5 Hz, 1H), 1.01 







Following a previously published protocol12, ((6-bromonaphthalen-2-yl)oxy)(tert-
butyl)dimethylsilane (1.0 g, 3 mmol), trimethylsilyl chloride (570 µL, 4.5 mmol), and n-butyl 
lithium solution (2.5 M, 1.8 mL, 4.5 mmol) gave a crude residue which was purified by flash 
chromatography (hexanes: ethyl acetate 99:1) to afford the desired product as a white solid 
(800 mg, 2.42 mmol, 81% yield). The spectral data matches that previously reported in the 
literature.8 
 
1H-NMR (500 MHz, CDCl3): δ 7.93 (s, 1H), 7.73 (d, J = 8.5 Hz, 1H), 7.68 (d, J = 8.0 Hz, 1H), 7.54 








Following general procedure A, 4-bromo-2-methylphenol (1.81 g, 9.68 mmol), imidazole (1.36 g, 
20 mmol), tert-butyldimethylsilyl chloride (2.26 g, 15 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 99:1) to afford the desired product as 
-S14- 
 
a colorless oil (2.54 g, 8.43 mmol, 87% yield). The spectral data matches that previously 
reported in the literature.13 
 
1H-NMR (500 MHz, CDCl3): δ 7.25 (d, J = 2.5 Hz, 1H), 7.15 (dd, J = 7.5, 2.5 Hz, 1H), 6.63 (d, J 







Following a previously published procedure,14 (4-bromo-2-methylphenoxy)(tert-
butyl)dimethylsilane (1.50 g, 4.98 mmol), phenyl boronic acid (915 mg, 7.5 mmol), potassium 
phosphate (6.37 g, 30 mmol), and PdCl2(PPh3)2 (176 mg, 0.25 mmol) in a mixture of toluene (15 
mL) and degassed water (15 mL) gave a crude residue which was purified by flash 
chromatography (hexanes: ethyl acetate 99:1) to afford the desired product as a colorless oil 
(1.03 g, 3.45 mmol, 69% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.55 (d, J = 8.0 Hz, 2H), 7.42-7.39 (m, 3H), 7.31-7.29 (m, 2H), 
6.84 (dd, J = 7.5 Hz, 2.5 Hz, 1H), 2.29 (s, 3H), 1.05 (s, 9H), 0.27 (s, 6H).   
13C-NMR (125 MHz, CDCl3): δ 153.54, 141.09, 134.0, 129.7, 129.1, 128.6, 126.7, 126.5, 125.2, 
118.7, 25.8, 18.3, 17.0, -4.2. 
IR (film, cm-1): 3029, 2956, 2927, 2857, 1610, 1510, 1486. 







Following a previously published protocol15, 2-bromopyridine (954 µL, 10 mmol), (4-
hydroxyphenyl)boronic acid (2.07 g, 15 mmol), and  palladium(II) acetate (11.2 mg, 0.05 mmol), 
and tripotassium phosphate (4.25 g, 20 mmol) gave a crude residue which was carried on to the 









Following general procedure A, crude mixture of 2-(4-((tert-
butyldimethylsilyl)oxy)phenyl)pyridine, imidazole (1.36 g, 20 mmol), and tert-butyldimethylsilyl 
chloride (2.26 g, 15 mmol) gave a crude mixture which was purified by flash chromatography 
(hexanes: ethyl acetate 95:5) to afford the desired product as a colorless oil (2.41 g, 8.44 mmol, 
84% over two steps). The spectral data matches that previously reported in the literature.8 
 
1H-NMR (500 MHz, CDCl3): δ 8.65 (d, J = 5.0 Hz, 1H), 7.88 (m, 2H), 7.71 (dt, 8.0, 2.0 Hz, 1H), 







Following general procedure A, 9H-carbazol-2-ol (940 mg, 5 mmol), imidazole (681 mg, 10 
mmol), and tert-butyldimethylsilyl chloride (1.13 g, 7.5 mmol) gave a crude residue which was 







Following a previously published protocol16, crude mixture of 2-((tert-butyldimethylsilyl)oxy)-9-
methyl-9H-carbazole, methyl iodine (342 µg, 5.5 mmol), and sodium hydride (300 mg, 12.5 
mmol) gave a crude residue which was purified by flash chromatography (hexanes: ethyl 
acetate 98:2) to afford the desired product as a white solid (544 mg, 1.75 mmol, 35% yield over 
two steps). The spectral data matches that previously reported in the literature.8 
 
1H-NMR (500 MHz, CDCl3): δ 7.99 (d, J = 7.5 Hz, 1H), 7.40 (m, 1H), 7.35 (d, J = 8.0 Hz, 1H), 
7.20 (t, J = 7.5 Hz, 1H), 6.83 (d, J = 2.0 Hz, 1H), 6.76 (dd, J = 8.0, 2.0 Hz, 1H), 3.78 (s, 3H), 









Following a previously published protocol17, 4-bromophenol (1.73 g, 10 mmol), methyl iodine 
(934 µL, 15 mmol), and potassium carbonate (2.76 g, 20 mmol) gave a crude residue which was 
purified by flash chromatography (100% hexanes) to afford the desired product as a clear oil 
(1.30 g, 6.95 mmol, 69%% yield). The spectral data matches that previously reported in the 
literature.18 
 








Following a previously published protocol15, 1-bromo-4methoxybenzene (1.25 g, 7 mmol), (4-
hydroxyphenyl)boronic acid (1.45 g, 10.5 mmol), and  palladium(II) acetate (15.7 mg, 0.07 
mmol), and tripotassium phosphate (2.97 g, 14 mmol) gave a crude residue which was carried 







Following general procedure A, crude mixture of 4'-methoxy-[1,1'-biphenyl]-4-ol, imidazole (953 
mg, 14 mmol), and tert-butyldimethylsilyl chloride (1.58 mg, 10.5 mmol) gave a crude mixture 
which was purified by recrystallization (EtOH) to afford the desired product as a white solid (1.06 
g, 3.4 mmol, 49% yield over two steps). The spectral data matches that previously reported in 
the literature.8 
 
1H-NMR (500 MHz, CDCl3): δ 7.47 (d, J = 8.5 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 6.95 (d, J = 9.0, 



















Following general procedure A, [1,1'-biphenyl]-4-ol (170 mg, 1 mmol), imidazole (136 mg, 2 
mmol), tert-butyldiphenylsilyl chloride (0.39 mL, 1.5 mmol) gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate = 99:1) to afford the desired product 
as a white solid (395 mg, 0.967 mmol, 97% yield). 
 
1H-NMR (500 MHz, CDCl3): δ 7.76 (d, J = 7.5 Hz, 4H), 7.50 (d, J = 7.5 Hz, 2H), 7.40 (m, 10H), 
7.27 (m, 1H), 6.85 (d, J = 8.5 Hz, 2H), 1.15 (s, 9H).  
13C-NMR (125 MHz, CDCl3): δ 155.2, 140.8, 135.5, 133.9, 132.9, 129.9, 128.6, 127.84, 127.78, 
126.63, 126.55, 119.9, 26.5, 19.5. 
IR (film, cm-1): 2930, 2857, 1604, 1516, 1484, 1252. 







Following general procedure A, [1,1'-biphenyl]-4-ol (440 mg, 2.588 mmol), imidazole (340 mg, 5 
mmol), triisopropylsilyl chloride (0.80 mL, 3.75 mmol) gave a crude residue which was purified 
by flash chromatography (hexanes: ethyl acetate = 99:1) to afford the desired product as a clear 
oil (722 mg, 2.211 mmol, 86% yield). The spectral data matches that previously reported in the 
literature.8 
 
1H-NMR (500 MHz, CDCl3): δ 7.55 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 6.5 Hz, 2H), 7.41 (t, J = 7.5 
Hz, 2H), 7.29 (t, J = 7.5 Hz, 1H), 6.94 (d, J = 8.5 Hz, 2H), 1.29 (septet, J = 7.5 Hz, 3H), 1.13 (d, 









Following general procedure A, [1,1'-biphenyl]-4-ol (3.57 g, 20.97 mmol), imidazole (2.86 g, 42 
mmol), chlorotriethylsilane (4.03 mL, 24 mmol) gave a crude residue which was purified by flash 
chromatography (hexanes: ethyl acetate = 99:1) to afford the desired product as a clear oil (5.01 
g, 17.61 mmol, 84% yield). The spectral data matches that previously reported in the literature.8 
 
1H-NMR (500 MHz, CDCl3): δ 7.56 (d, J = 7.5 Hz, 2H), 7.47 (m, 2H), 7.42 (t, J = 7.5 Hz, 2H), 







Following a previously published protocol19, 4-phenylphenol (1.19 g, 7 mmol), iodomethane 
(0.87 mL, 14 mmol), potassium carbonate (4.93 g, 14 mmol) gave a crude residue that was 
purified by flash column chromatography (100% hexanes) to afford the desired product as a 
white solid (1.27 mg, 6.89 mmol, 99% yield). The spectral data matches that previously reported 
in the literature.19 
 
1H-NMR (500 MHz, CDCl3): δ 7.54 (m, 4H), 7.42 (t, J = 7.5 Hz, 2H), 7.13 (t, J = 7.5 Hz, 1H), 







Following a previously published protocol1, 4-phenylphenol (343 mg, 2 mmol), iodobenzene 
(336 µL, 3 mmol), iron (III) chloride (64.9 mg, 0.4 mmol), cesium carbonate (1.3 g, 4 mmol), 
2,2,6,6-Tetramethyl-3,5-heptanedione (167 mg, 0.4 mmol) gave a crude residue that was 
purified by flash column chromatography (100% hexanes) to afford the desired product as a 
white solid (340 mg, 1.38 mmol, 69% yield). The spectral data matches that previously reported 
in the literature.20 
 
1H-NMR (500 MHz, CDCl3): δ 7.56 (m, 4H), 7.44 (t, J = 8.0 Hz, 2H), 7.35 (m, 3H), 7.13 (t, J = 
8.0 Hz, 1H), 7.07 (m, 4H).  
 
 
[1,1'-biphenyl]-4-yl pivalate (1-Piv). 
 
                                                          





Following a previously published protocol21, 4-phenylphenol (851 mg, 5 mmol), pivaloyl chloride 
(739 µL, 6 mmol), triethylamine (0.84 mL, 6 mmol), 4-(dimethylamino)-pyridine (61.1 mg, 0.6 
mmol) gave a crude residue that was purified by flash column chromatography (100% hexanes) 
to afford the desired product as a white solid (1.108 g, 4.36 mmol, 85% yield). The spectral data 
matches that previously reported in the literature.20 
 
1H-NMR (500 MHz, CDCl3): δ 7.59 (m, 4H), 7.44 (t, J = 7.5 Hz, 2H), 7.35 (t, J = 7.5 Hz, 1H), 
7.13 (m, 2H), 1.38 (s, 9H).  
 
 




Following a previously published protocol22, 4-phenylphenol (871 mg, 5.12 mmol), 
trifluoromethanesulfonic anhydride (841 µL, 5 mmol), 2,6-dimethylpyridine (1.75 mL, 15 mmol) 
gave a crude residue that was purified by flash column chromatography (100% hexanes) to 
afford the desired product as a white solid (1.34 g, 4.43 mmol, 84% yield). The spectral data 
matches that previously reported in the literature.20 
 
1H-NMR (500 MHz, CDCl3): δ 7.65 (m, 4H), 7.56 (d, J = 7.5 Hz, 2H), 7.47 (t, J = 7.5 Hz, 2H), 




























Following a modified general procedure B (5 mol% catalyst loading), Ni(COD)2 (4.1 mg, 0.015 
mmol), IPrMe·HCl (13.6 mg, 0.03 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-
yloxy)(tert-butyl)dimethylsilane (79.3 mg, 0.279 mmol), and morpholine (39 µL, 0.45 mmol) at 
120 °C for 16 h gave a crude residue which was purified by flash chromatography (hexanes: 
ethyl acetate 92.5:7.5) to afford the desired product (62.3 mg, 0.260 mmol, 93% yield). The 
spectral data matches that previously reported in the literature.23 
 
1H-NMR (500 MHz, CDCl3): δ 7.55 (m, 4H), 7.41 (t, J = 7.5 Hz, 2H), 7.29 (t, J = 7.5 Hz, 1H), 







Following general procedure B, Ni(COD)2 (8.2 mg, 0.03 mmol), IPrMe·HCl (27.2 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (84.0 mg, 
0.295 mmol), and 1-methylpiperazine (50 µL, 0.45 mmol) at 120 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate:triethylamine 
72.5:25:2.5) to afford the desired product (64.6 mg, 0.256 mmol, 87% yield). The spectral data 
matches that previously reported in the literature.24 
 
1H-NMR (500 MHz, CDCl3): δ 7.58 (d, J = 7.0 Hz, 2H), 7.54 (dd, J = 8.0 Hz, 3.0 Hz, 2H), 7.42 (t, 
J = 7.5 Hz, 2H), 7.30 (t, J = 7.5 Hz, 1H), 7.01 (d, J = 7.5 Hz, 2H), 3.29 (t, J = 5.0 Hz, 4H), 2.61 









Following general procedure B, Ni(COD)2 (8.2 mg, 0.03 mmol), IPrMe·HCl (27.2 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (85.3 mg, 
0.300 mmol), and 2-methylpiperidine (53 µL, 0.45 mmol) at 120 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the 
desired product (57.9 mg, 0.230 mmol, 77% yield). The spectral data matches that previously 
reported in the literature.24 
 
1H-NMR (500 MHz, CDCl3): δ 7.56 (d, J = 8.0 Hz, 2H), 7.50 (d, J = 7.5 Hz, 2H), 7.40 (t, J = 8.0 
Hz, 2H), 7.27 (m, 1H), 6.98 (d, J = 7.5 Hz, 2H), 4.02 (s, 1H), 3.32 (dt, J = 12.2, 4.0 Hz, 1H), 3.0 







Following general procedure B, Ni(COD)2 (8.3 mg, 0.03 mmol), IPrMe·HCl (27.2 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (84.0 mg, 
0.295 mmol), and 2,6-dimethylpiperdine (49 µL, 0.45 mmol) at 120 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the 
desired product (18.3 mg, 0.069 mmol, 23% yield). 
 
1H-NMR (500 MHz, CDCl3): δ 7.59 (d, J = 8.5 Hz, 2H), 7.53 (d, J = 8.5 Hz, 2H), 7.42 (t, J = 8.0 
Hz, 2H), 7.30 (t, J = 7.0 Hz, 1H), 7.16 (d, J = 8.5 Hz, 2H), 3.10 (m, 2H), 1.77 (m, 3H), 1.53 (m, 
3H), 0.87 (d, J = 6.5 Hz, 6H). 
13C-NMR (125 MHz, CDCl3): δ 150.0, 140.9, 136.3, 128.7, 128.3, 126.8, 126.7, 124.9, 55.9, 
34.5, 22.6, 21.4. 
IR (film, cm-1): 2956, 2924, 2855, 2791, 1602, 1485. 









Following a modified general procedure B (15 mol% catalyst loading and 2.5 equiv. of amine), 
Ni(COD)2 (12.4 mg, 0.045 mmol), IPrMe·HCl (40.8 mg, 0.09 mmol), NaO-t-Bu (72.0 mg, 0.750 
mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (87.4 mg, 0.307 mmol), and 
diisobutylamine (131 µL, 0.75 mmol) at 120 °C for 16 h gave a crude residue which was purified 
by flash chromatography (hexanes) to afford the desired product (16.4 mg, 0.058 mmol, 19% 
yield). 
 
1H-NMR (500 MHz, CDCl3): δ 7.54 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 7.5 Hz, 2H), 7.38 (t, J = 7.5 
Hz, 2H), 7.23 (t, J = 7.5 Hz, 1H), 6.71 (d, J = 8.5 Hz, 2H), 3.19 (d, J = 7.0 Hz, 4H), 2.13 (septet, 
J = 7.0 Hz, 2H), 0.92 (d, J = 7.0 Hz, 12H). 
13C-NMR (125 MHz, CDCl3): δ 147.6, 141.3, 128.8, 128.7, 128.6, 126.1, 125.7, 115.5, 60.4, 
26.4, 20.4. 
IR (film, cm-1): 2948, 2929, 2863, 1609, 1518, 1486. 
HRMS (ESI+) m/z: [M+H]+ predicted for C20H27N, 282.2216; found, 282.2219. 
 
 




Following a modified general procedure B (15 mol% catalyst loading and 2.5 equiv. of amine), 
Ni(COD)2 (12.4 mg, 0.045 mmol), IPrMe·HCl (40.8 mg, 0.09 mmol), NaO-t-Bu (72.0 mg, 0.750 
mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (85.9 mg, 0.302 mmol), and 
dibutylamine (126 µL, 0.75 mmol) at 120 °C for 16 h gave a crude residue which was purified by 
flash chromatography (hexanes: ethyl acetate 99:1) to afford the desired product (69.8 mg, 
0.248 mmol, 82% yield). The spectral data matches that previously reported in the literature.25 
 
1H-NMR (500 MHz, CDCl3): δ 7.55 (d, J = 8.0 Hz, 2H), 7.47 (d, J = 8.0 Hz, 2H), 7.24 (m, 1H), 








Following general procedure B, Ni(COD)2 (8.2 mg, 0.03 mmol), IPrMe·HCl (27.2 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (84.8 mg, 
0.298 mmol), and N-methylbutylamine (53 µL, 0.45 mmol) at 120 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the 




1H-NMR (500 MHz, CDCl3): δ 7.56 (d, J = 7.5 Hz, 2H), 7.51 (d, J = 8.0 Hz, 2H), 7.39 (t, J = 7.0 
Hz, 2H), 7.25 (m, 1H), 6.77 (d, J = 8.0 Hz, 2H), 3.36 (t, J = 7.5 Hz, 2H), 2.98 (s, 3H), 1.60 (m, 
2H), 1.38 (m, 2H), 0.97 (t, J = 7.5 Hz, 3H). 
13C-NMR (125 MHz, CDCl3): δ 148.7, 141.3, 128.6, 128.4, 127.7, 126.2, 125.8, 112.2, 52.5, 
38.4, 28.9, 20.4, 14.0.  
IR (film, cm-1): 3033, 2952, 2870, 1608, 1527, 1491. 
HRMS (ESI+) m/z: [M+H]+ predicted for C17H21N, 240.1747; found, 240.1748. 
 
 




Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-
butyl)dimethylsilane (84.8 mg, 0.298 mmol), and N-methylaniline (81 µL, 0.75 mmol) at 120 °C 
for 16 h gave a crude residue which was purified by flash chromatography (hexanes: toluene 
90:10) to afford the desired product (33.2 mg, 0.128 mmol, 43% yield). The spectral data 
matches that previously reported in the literature.26 
 
1H-NMR (500 MHz, CDCl3): δ 7.56 (d, J = 7.0 Hz, 2H), 7.50 (d, J = 7.5 Hz, 2H), 7.41 (t, J = 7.5 
Hz, 2H), 7.31 (m, 2H), 7.11 (d, J = 8.0 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 7.01 (t, J = 7.0 Hz, 1H), 
3.36 (s, 3H). 
 
 




Following general procedure B, Ni(COD)2 (8.2 mg, 0.03 mmol), IPrMe·HCl (27.6 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (84.1 mg, 
0.296 mmol), and 2,4,6-trimethylaniline (63 µL, 0.45 mmol) at 120 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the 
desired product (68.0 mg, 0.237 mmol, 80% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.54 (d, J = 8.0 Hz, 2H), 7.41 (m, 4H), 7.26 (t, J = 7.5 Hz, 1H), 
6.98 (s, 2H), 6.57 (d, J = 8.5 Hz, 2H), 2.34 (s, 3H), 2.22 (s, 6H). 
13C-NMR (125 MHz, CDCl3): δ 146.1, 141.2, 136.0, 135.5, 135.3, 130.8, 129.2, 128.6, 127.9, 
126.3, 126.1, 113.5, 20.9, 18.3.  
IR (film, cm-1): 3390, 3022, 2916, 1613, 1519, 1484. 
HRMS (ESI+) m/z: [M+H]+ predicted for C21H21N, 288.1747; found, 288.1753. 
-S24- 
 




Following a modified general procedure B (15 mol% catalyst loading and 2.5 equiv. of amine), 
Ni(COD)2 (12.4 mg, 0.045 mmol), IPrMe·HCl (40.8 mg, 0.09 mmol), NaO-t-Bu (72.0 mg, 0.750 
mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (84.7 mg, 0.298 mmol), and 2,6-
diisopropylaniline (131 µL, 0.75 mmol) at 120 °C for 16 h gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the desired product 
(54.0 mg, 0.164 mmol, 55% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.56 (d, J = 7.5 Hz, 2H), 7.40 (m, 4H), 7.33 (t, J = 7.5 Hz, 1H), 
7.26 (m, 2H), 6.57 (d, J = 8.0 Hz, 2H), 5.21 (s, 1H), 3.25 (septet, J = 7.0 Hz, 2H), 1.18 (d, J = 
7.0 Hz, 12H). 
13C-NMR (125 MHz, CDCl3): δ 147.6, 141.1, 135.0, 130.5, 128.6, 127.8, 127.3, 126.2, 126.0, 
123.9, 115.6, 113.2, 28.2, 23.9.  
IR (film, cm-1): 3398, 3031, 2961, 2867, 1612, 1521, 1486. 
HRMS (ESI+) m/z: [M+H]+ predicted for C24H27N, 330.2216; found, 330.2217. 
 
 




Following a modified general procedure B (15 mol% catalyst loading and 2.5 equiv. of amine), 
Ni(COD)2 (12.4 mg, 0.045 mmol), IPrMe·HCl (40.8 mg, 0.09 mmol), NaO-t-Bu (72.0 mg, 0.750 
mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (84.7 mg, 0.298 mmol), and aniline (68 
µL, 0.75 mmol) at 120 °C for 16 h gave a crude residue which was analyzed by 1H-NMR and 










Following general procedure B, Ni(COD)2 (4.1 mg, 0.015 mmol), IPrMe·HCl (13.6 mg, 0.03 
mmol), NaO-t-Bu (36.0 mg, 0.375 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (41.2 
mg, 0.145 mmol), and cyclohexylamine (26 µL, 0.225 mmol) at 120 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the 
desired product (31.8 mg, 0.127 mmol, 87% yield). The spectral data matches that previously 
reported in the literature.28 
 
1H-NMR (500 MHz, CDCl3): δ 7.52 (d, J = 7.5 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 7.38 (t, J = 8.0 
Hz, 2H), 7.24 (m, 1H), 6.69 (m, 2H), 3.67 (bs, 1H), 3.30 (m, 1H), 2.09 (dd, J = 12.5 Hz, 3.0 Hz, 
2H), 13.5 Hz, 4.0 Hz, 2H), 1.66 (m, 1H), 1.38 (m, 2H), 1.28-1.19 (m, 3H). 
 
 




Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.6 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-
butyl)dimethylsilane (85.4 mg, 0.300 mmol), and cyclopropylmethylamine (65 µL, 0.75 mmol) at 
120 °C for 16 h gave a crude residue which was purified by flash chromatography (hexanes: 
ethyl acetate 95:5) to afford the desired product (47.4 mg, 0.212 mmol, 71% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.54 (d, J = 7.5 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 7.39 (t, J = 7.5 
Hz, 2H), 7.26 (m, 1H), 6.69 (d, J = 8.5 Hz, 2H), 3.88 (br, 1H), 3.01 (d, J = 7.0 Hz, 2H), 1.13 (m, 
1H), 0.57 (d, J = 7.5 Hz, 2H), 0.27 (d, J = 5.0 Hz, 2H). 
13C-NMR (125 MHz, CDCl3): δ 147.9, 141.3, 130.1, 128.6, 127.9, 126.3, 126.0, 113.0, 49.1, 
10.9, 3.5. 
IR (film, cm-1): 2926, 2853, 1609, 1503, 1471. 
HRMS (ESI+) m/z: [M+H]+ predicted for C16H17N, 224.1434; found, 224.1433. 
 
 




Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-
butyl)dimethylsilane (87.3 mg, 0.307 mmol), and butylamine (74 µL, 0.75 mmol) at 120 °C for 16 
h gave a crude residue which was purified by flash chromatography (hexanes: ethyl acetate 
95:5) to afford the desired product (48.0 mg, 0.213 mmol, 69% yield). The spectral data 




1H-NMR (500 MHz, CDCl3): δ 7.53 (d, J = 7.0 Hz, 2H), 7.44 (d, J = 8.5 Hz, 2H), 7.39 (t, J = 8.0 
Hz, 2H), 7.25 (m, 1H), 6.70 (d, J = 8.5 Hz, 2H), 3.91 (bs, 1H), 3.16 (t, J = 7.0 Hz, 2H), 1.64 
(pentet, J = 7.5 Hz, 2H), 1.45 (sextet, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H).    
 
 




Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-
butyl)dimethylsilane (83.9 mg, 0.295 mmol), and isobutylamine (75 µL, 0.75 mmol) at 120 °C for 
16 h gave a crude residue which was purified by flash chromatography (hexanes: ethyl acetate 
95:5) to afford the desired product (50.0 mg, 0.222 mmol, 75% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.57 (d, J = 6.5 Hz, 2H), 7.47 (d, J = 8.5 Hz, 2H), 7.42 (t, J = 7.5 
Hz, 2H), 7.28 (t, J = 7.0 Hz, 1H), 6.70 (d, J = 8.5 Hz, 2H), 3.83 (bs, 1H), 3.00 (d, J = 7.0 Hz, 2H), 
1.95 (septet, J = 7.0 Hz, 1H), 1.03 (d, J = 6.5 Hz, 6H). 
13C-NMR (125 MHz, CDCl3): δ 148.0, 141.3, 129.8, 128.6, 127.9, 126.2, 125.9, 112.8, 51.8, 
28.0, 20.5.  
IR (film, cm-1): 3393, 2951, 2927, 2854, 1610, 1492. 
HRMS (EI) m/z: [M]+ predicted for C16H19N, 225.1517; found, 225.1513. 
 
 




Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-
butyl)dimethylsilane (86.0 mg, 0.302 mmol), and sec-butylamine (76 µL, 0.75 mmol) at 120 °C 
for 16 h gave a crude residue which was purified by flash chromatography (hexanes: ethyl 
acetate 95:5) to afford the desired product (45.4 mg, 0.201 mmol, 67% yield). The spectral data 
matches that previously reported in the literature.30 
 
1H-NMR (500 MHz, CDCl3): δ 7.53 (d, J = 8.0 Hz, 2H), 7.44-7.37 (m, 4H), 7.25 (m, 11H), 6.65 
(d, J = 7.0 Hz, 2H), 3.55 (bs, 1H), 3.44 (m, 1H), 1.61 (m, 1H), 1.50 (m, 1H), 1.21 (d, J = 5.5 Hz, 
3H), 0.98 (t, J = 7.0 Hz, 3H). 
 
 






Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-
butyl)dimethylsilane (87.5 mg, 0.308 mmol), and cyclobutylamine (64 µL, 0.75 mmol) at 120 °C 
for 16 h gave a crude residue which was purified by flash chromatography (hexanes: ethyl 
acetate 95:5) to afford the desired product (37.7 mg, 0.169 mmol, 55% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.56 (d, J = 7.0 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 7.41 (t, J = 7.5 
Hz, 2H), 7.27 (t, J = 7.5 Hz, 1H), 6.64 (d, J = 8.5 Hz, 2H), 3.98 (m, 1H), 3.92 (bs, 1H), 2.47 (m, 
2H), 1.88 (m, 4H). 
13C-NMR (125 MHz, CDCl3): δ 146.6, 141.3, 130.2, 128.6, 127.9, 126.3, 126.0, 113.2, 48.9, 
31.2, 15.3. 
IR (film, cm-1): 3380, 2954, 2928, 2853, 1607, 1518, 1472. 
HRMS (ESI+) m/z: [M+H]+ predicted for C16H17N, 224.1434; found, 224.1438. 
 
 




Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), ([1,1'-biphenyl]-4-yloxy)(tert-
butyl)dimethylsilane (83.2 mg, 0.292 mmol), and tert-butylamine (79 µL, 0.75 mmol) at 120 °C 
for 16 h gave a crude residue which was purified by flash chromatography (hexanes: ethyl 
acetate 95:5) to afford the desired product (10.2 mg, 0.045 mmol, 15% yield). The spectral data 
matches that previously reported in the literature.31 
 
1H-NMR (500 MHz, CDCl3): δ 7.54 (d, J = 7.5 Hz, 2H), 7.43-7.37 (m, 4H), 7.26 (m, 1H), 6.82 (m, 
2H), 3.62 (bs, 1H), 1.38 (s, 9H).  
 
 




Following a modified general procedure B (15 mol% catalyst loading and 2.5 equiv. of amine), 
Ni(COD)2 (12.4 mg, 0.045 mmol), IPrMe·HCl (40.8 mg, 0.09 mmol), NaO-t-Bu (72.0 mg, 0.750 
-S28- 
 
mmol), ([1,1'-biphenyl]-4-yloxy)(tert-butyl)dimethylsilane (87.5 mg, 0.308 mmol), and 1-
adamantylamine (113.4 mg, 0.75 mmol) at 120 °C for 16 h gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the desired product 
(51.9 mg, 0.171 mmol, 56% yield). The spectral data matches that previously reported in the 
literature.32 
 
1H-NMR (500 MHz, CDCl3): δ 7.53 (d, J = 7.5 Hz, 2H), 7.41-7.37 (m, 4H), 7.26 (m, 1H), 6.65 (d, 








Following a modified general procedure B (4.0 equiv. of base), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (115.6 mg, 1.20 mmol), tert-
butyldimethyl(naphthalen-1-yloxy)silane (77.5 mg, 0.300 mmol), and benzylamine (50 µL, 0.45 
mmol) at 120 °C for 16 h gave a crude residue which was purified by flash chromatography 
(hexanes: ethyl acetate 99:1) to afford the desired product (53.0 mg, 0.227 mmol, 76% yield). 
The spectral data matches that previously reported in the literature.28 
 
1H-NMR (500 MHz, CDCl3): δ 7.83 (t, J = 7.5 Hz, 2H), 7.46 (m, 4H), 7.39 (t, J = 7.5 Hz, 2H), 







Following general procedure B, Ni(COD)2 (8.2 mg, 0.03 mmol), IPrMe·HCl (27.2 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.75 mmol), tert-butyldimethyl(naphthalen-2-yloxy)silane (79.4 mg, 0.307 
mmol), and isobutylamine (45 µL, 0.45 mmol) at 120 °C for 16 h gave a crude residue which 
was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the desired product 
(42.5 mg, 0.213 mmol, 69% yield). The spectral data matches that previously reported in the 
literature.29 
 
1H-NMR (500 MHz, CDCl3): δ 7.66 (8.0 Hz, 1H), 7.61 (m, 2H), 7.35 (t, J = 7.5 Hz, 1H), 7.18 (t, J 
= 7.5 Hz, 2H), 6.88 (dd, J = 8.5 Hz, 2.0 Hz, 1H), 6.80 (d, J = 2.0 Hz, 1H), 3.90 (bs, 1H), 3.05 (d, 
J = 7.0 Hz, 2H), 1.98 (septet, J = 6.5 Hz, 1H), 1.04 (d, J = 7.0 Hz, 6H). 
13C-NMR (125 MHz, CDCl3): δ 146.2, 135.3, 128.8, 127.6, 127.3, 126.2, 125.8, 121.7, 117.9, 
104.1, 51.8, 28.0, 20.6.  
IR (film, cm-1): 3421, 3050, 2955, 2868, 1629, 1522. 









Following general procedure B, Ni(COD)2 (8.2 mg, 0.03 mmol), IPrMe·HCl (27.2 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.750 mmol), tert-butyldimethyl((6-(trimethylsilyl)naphthalen-2-yl)oxy)silane 
(99.8 mg, 0.302 mmol), and N-methylaniline (49 µL, 0.45 mmol) gave a crude residue which 
was purified by flash chromatography (hexanes: ethyl acetate 99:1) to afford the desired product 
(56.4 mg, 0.184 mmol, 61% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.91 (s, 1H), 7.69 (d, J = 8.5 Hz, 2H), 7.55 (d, J = 8.0 Hz, 1H), 
7.32 (m, 3H), 7.21 (m, 1H), 7.12 (d, J = 8.5 Hz, 2H), 7.04 (t, J = 7.5 Hz, 1H), 3.44 (s, 3H), 0.36 
(s, 9H). 
13C-NMR (125 MHz, CDCl3): δ 149.0, 146.9, 135.1, 134.9, 133.4, 130.3, 129.3, 128.7, 128.6, 
125.8, 122.1, 121.64, 121.61, 114.0, 40.6, -1.0. 
IR (film, cm-1): 3038, 2952, 1625, 1589, 1488. 
HRMS (ESI+) m/z: [M+H]+ predicted for C20H23NSi, 306.1673; found, 306.1669. 
 
 




Following general procedure B, Ni(COD)2 (4.1 mg, 0.015 mmol), IPrMe·HCl (13.6 mg, 0.03 
mmol), NaO-t-Bu (36.0 mg, 0.375 mmol), tert-butyldimethyl((3-methyl-[1,1'-biphenyl]-4-
yl)oxy)silane (46.2 mg, 0.155 mmol), and N-benzylmethylamine (29 µL, 0.225 mmol) at 120 °C 
for 16 h gave a crude residue which was purified by flash chromatography (hexanes: ethyl 
acetate 95:5) to afford the desired product (28.9 mg, 0.101 mmol, 65% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.59 (d, J = 7.5 Hz, 2H), 7.46-7.16 (m, 10H), 7.15 (d, J = 8.0 Hz, 
1H), 4.10 (s, 2H), 2.64 (s, 3H), 2.48 (s, 3H). 
13C-NMR (125 MHz, CDCl3): δ 151.8, 141.0, 139.0, 135.7, 132.9, 129.9, 128.6, 128.32, 128.30, 
127.0, 126.8, 126.7, 125.1, 120.2, 60.7, 40.8, 18.7. 
IR (film, cm-1): 3060, 3028, 2948, 2791, 1603, 1485. 
HRMS (ESI+) m/z: [M+H]+ predicted for C21H22N, 288.1747; found, 288.1748. 
 
 






Following a modified general procedure B (15 mol% catalyst loading, 2.5 equiv. of amine, 4.0 
equiv. of base, at 130 °C), Ni(COD)2 (6.2 mg, 0.0225 mmol), IPrMe·HCl (20.4 mg, 0.045 mmol), 
NaO-t-Bu (57.7 mg, 0.6 mmol), ([1,1'-biphenyl]-2,5-diylbis(oxy))bis(tert-butyldimethylsilane) 
(63.2 mg, 0.152 mmol), and morpholine (33 µL, 0.375 mmol) at 130 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the 
desired product (27.0 mg, 0.073 mmol, 48% yield). The product was isolated as a mixture of the 
desired product and 4-([1,1'-biphenyl]-3-yl)morpholine. The spectral data for 4-([1,1'-biphenyl]-3-
yl)morpholine matches that previously reported in the literature.33  
 
Pure 4-(6-((tert-butyldimethylsilyl)oxy)-[1,1'-biphenyl]-3-yl)morpholine (6) could be obtained by 
deprotecting the tert-butyldimethylsilyl group, separating 5-morpholino-[1,1'-biphenyl]-2-ol from 
4-([1,1'-biphenyl]-3-yl)morpholine, and reprotecting 5-morpholino-[1,1'-biphenyl]-2-ol to obtain 4-
(6-((tert-butyldimethylsilyl)oxy)-[1,1'-biphenyl]-3-yl)morpholine (6): in a round bottom flask, the 
mixture of 4-(6-((tert-butyldimethylsilyl)oxy)-[1,1'-biphenyl]-3-yl)morpholine and 4-([1,1'-
biphenyl]-3-yl)morpholine was dissolved in THF (5 mL) and TBAF (6.5 equiv., 1.95 mmol, 1.95 
mL of 1 M THF solution) was added and stirred for 1 hour at rt. The reaction mixture was 
quenched with deionized H2O (5 mL) and extracted with ethyl acetate (3 x 20 mL) which gave a 
crude residue that was purified by flash column chromatography (hexanes ethyl acetate 80:20). 
In a round bottom flask, pure 5-morpholino-[1,1'-biphenyl]-2-ol was dissolved in CH2Cl2 (0.6 
mL). The solution was then charged with imidazole (2 equiv., 40.8 mg, 0.6 mmol) and tert-
butyldimethylchlorosilane (1.5 equiv., 67.8 mg, 0.45 mmol) and stirred for 30 minutes at rt. The 
reaction was quenched with deionized H2O (10 mL), extracted with Et2O (3 x 20 mL), dried over 
MgSO4, filtered, concentrated under reduced pressure and purified by flash column 
chromatography on silica gel to afford the title compound. 
 
 
1H-NMR (500 MHz, CDCl3): δ 7.48 (d, J = 7.0 Hz, 2H), 7.36 (t, J = 7.5 Hz, 2H), 7.29 (t, J = 7.5 
Hz, 1H), 6.89 (d, J = 3.0 Hz, 1H), 6.84 (d, J = 9.0 Hz, 1H), 6.80 (dd, J = 8.5, 3.0 Hz, 1H), 3.87 (t, 
J = 5.0 Hz, 4H), 3.11 (t, J = 5.0 Hz, 4H), 0.81 (s, 9H), -0.11 (s, 6H). 
13C-NMR (175 MHz, CDCl3): δ 146.5, 145.9, 139.4, 133.8, 129.7, 127.8, 126.7, 120.9, 118.9, 
116.2, 67.1, 50.5, 25.6, 18.0, -4.7.  
IR (film, cm-1): 3032, 2957, 2928, 2855, 1599, 1486. 









Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (8.2 mg, 0.03 mmol), 
IPrMe·HCl (27.2 mg, 0.06 mmol), NaO-t-Bu (72.0 mg, 0.750 mmol), 6-((tert-
butyldimethylsilyl)oxy)-2-methylquinoline (82.6 mg, 0.302 mmol), and 1-(2-pyrimidyl)piperazine 
(106 µL, 0.75 mmol) at 120 °C for 16 h gave a crude residue which was purified by flash 
chromatography (hexanes: ethyl acetate: triethylamine 85:12.5:2.5) to afford the desired product 
(65.8 mg, 0.215 mmol, 71% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 8.35 (d, J = 5 Hz, 2H), 7.92 (t, J = 9.0 Hz, 2H), 7.51 (dd, J = 7.0, 
1.5 Hz, 1H), 7.21 (d, J = 7.5 Hz, 1H), 7.05 (d, J = 1.5 Hz, 1H), 6.53 (t, J = 4.5 Hz, 2H), 4.04 (t, J 
= 5.0 Hz, 4H), 3.36 (t, J = 5.0Hz, 4H), 2.70 (s, 3H). 
13C-NMR (125 MHz, CDCl3): δ 161.7, 157.7, 156.2, 148.8, 143.6, 135.0, 129.4, 127.4, 122.7, 
122.2, 110.2, 110.0, 109.8, 49.5, 43.6, 25.0. 
IR (film, cm-1): 2362, 2322, 1584, 1546, 1498, 1448. 







Following general procedure B, Ni(COD)2 (8.2 mg, 0.03 mmol), IPrMe·HCl (27.2 mg, 0.06 mmol), 
NaO-t-Bu (72.0 mg, 0.750 mmol), 2-(4-((tert-butyldimethylsilyl)oxy)phenyl)pyridine (85.0 mg, 
0.298 mmol), and N-octylamine (73 µL, 0.45 mmol) gave a crude residue which was purified by 
flash chromatography (hexanes: ethyl acetate 90:10) to afford the desired product (62.0 mg, 
0.220 mmol, 74% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 8.61 (d, J = 5.0 Hz, 1H), 7.86 (d, J = 9.0 Hz, 2H), 7.64 (m, 2H), 
7.09 (t, J = 5.5 Hz, 1H), 6.67 (d, J = 8.5 Hz, 2H), 3.83 (b, 1H), 3.16 (t, J = 7.0 Hz, 2H), 1.63 
(pentet, J = 7.5 Hz, 2H), 1.40 (m, 2H), 1.31 (m, 8H), 0.90 (t, J = 8.0 Hz, 3H). 
13C-NMR (125 MHz, CDCl3): δ 157.6, 149.3, 149.3, 136.4, 128.0, 127.9, 120.5, 119.0, 112.5, 
43.8, 29.5, 29.4, 29.2, 27.1, 22.6, 14. 
IR (film, cm-1): 3392, 2922, 2851, 2361, 1612, 1582, 1460. 
HRMS (EI) m/z: [M]+ predicted for C19H26N2, 282.2096; found, 282.2093. 
 
 




Following general procedure B, Ni(COD)2 (4.1 mg, 0.015 mmol), IPrMe·HCl (13.6 mg, 0.03 
mmol), NaO-t-Bu (36.0 mg, 0.375 mmol), 2-((tert-butyldimethylsilyl)oxy)-9-methyl-9H-carbazole 
(46.9 mg, 0.151 mmol), and cyclohexylamine (26 µL, 0.225 mmol) at 120 °C for 16 h gave a 
-S32- 
 
crude residue which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to 
afford the desired product (30.4 mg, 0.109 mmol, 73% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.90 (d, J = 7.5 Hz, 1H), 7.81 (d, J = 8.5 Hz, 1H), 7.34-7.28 (m, 
2H), 7.15 (t, J = 7.5 Hz, 1H), 6.53 (dd, J = 8.0, 2.0 Hz, 1H), 6.51 (d, J = 2.0 Hz, 1H), 3.75 (s, 
3H), 3.42 (m, 1H), 2.15 (dd, J = 13.5, 4.0 Hz, 2H), 1.81 (m, 2H), 1.70 (m, 1H), 1.45 (m, 2H), 1.25 
(m, 3H).   
13C-NMR (125 MHz, CDCl3): δ 146.8, 143.1, 140.7, 123.64, 123.61, 123.3, 121.1, 118.6, 114.1, 
107.8, 107.6, 91.2, 52.2, 33.6, 28.9, 26.0, 25.1. 
IR (film, cm-1): 3033, 2952, 2870, 1608, 1527, 1491. 
HRMS (ESI+) m/z: [M+H]+ predicted for C19H22N2, 279.1856; found, 279.1862. 
 
 




Following a modified general procedure B (2.5 equiv. of amine), Ni(COD)2 (4.1 mg, 0.015 
mmol), IPrMe·HCl (13.6 mg, 0.03 mmol), NaO-t-Bu (36.0 mg, 0.375 mmol), 3-((tert-
butyldimethylsilyl)oxy)quinoline (40.7 mg, 0.157 mmol), and dibutylamine (63 µL, 0.375 mmol) at 
120 °C for 16 h gave a crude residue which was purified by flash chromatography (hexanes: 
ethyl acetate 95:5) to afford the desired product (25.5 mg, 0.099 mmol, 63% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 8.63 (d, J = 3.0 Hz, 1H), 7.91 (d, J = 7.5 Hz, 1H), 7.59 (d, J = 7.0 
Hz, 1H), 7.38 (m, 2H), 7.04 (d, J = 3.0 Hz, 1H), 3.39 (t, J = 8.0 Hz, 4H), 1.63 (pentet, J = 8.0 Hz, 
4H), 1.40 (sextet, J = 7.5 Hz, 4H), 0.98 (t, J = 7.5 Hz, 6H). 
13C-NMR (125 MHz, CDCl3): δ 141.7, 141.1, 140.8, 129.5, 128.8, 126.7, 125.8, 124.4, 111.4, 
50.8, 29.3, 20.3, 14.0. 
IR (film, cm-1): 3062, 2956, 2929, 2871, 2208, 1697, 1594. 







Following a modified general procedure B (15 mol% catalyst loading, 4.0 equiv. of base), 
Ni(COD)2 (12.4 mg, 0.045 mmol), IPrMe·HCl (40.8 mg, 0.09 mmol), NaO-t-Bu (115.3 mg, 1.20 
mmol), tert-butyl((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)dimethylsilane (95.4 mg, 0.303 mmol), and 
1-methylpiperazine (50 µL, 0.45 mmol) at 120 °C for 16 h gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate: triethylamine 85:12.5:2.5) to afford 




1H-NMR (500 MHz, CDCl3): δ 7.48 (t, J = 8.0 Hz, 4H), 6.98 (m, 4H), 3.84 (m, 3H), 3.26 (t, J = 
5.0 Hz, 4H), 2.60 (t, J = 5.0 Hz, 4H), 2.37 (s, 3H). 
13C-NMR (125 MHz, CDCl3): δ 158.5, 150.1, 133.5, 132.0, 127.5, 127.3, 116.1, 114.1, 55.3, 
55.1, 49.0, 46.1. 
IR (film, cm-1): 2932, 2840, 2790, 1606, 1500, 1443. 
HRMS (ESI+) m/z: [M+H]+ predicted for C18H22N2O, 283.1805; found, 283.1802. 
 
 




Following general procedure B, Ni(COD)2 (4.1 mg, 0.015 mmol), IPrMe·HCl (13.6 mg, 0.03 
mmol), NaO-t-Bu (36.0 mg, 0.375 mmol), ([1,1'-biphenyl]-3-yloxy)(tert-butyl)dimethylsilane (41.8 
mg, 0.147 mmol), and tert-butyl 4-aminopiperidine-1-carboxylate (45.1 mg, 0.225 mmol) at 120 
°C for 16 h gave a crude residue which was purified by flash chromatography (hexanes: ethyl 
acetate 95:5) to afford the desired product (30.0 mg, 0.085 mmol, 60% yield).  
 
1H-NMR (700 MHz, CDCl3): δ 7.56 (d, J = 7.7 Hz, 2H), 7.42 (t, J = 7.7 Hz, 2H), 7.34 (t, J = 7.0 
Hz, 1H), 7.24 (t, J = 7.7 Hz, 1H), 6.93 (d, J = 7.7 Hz, 1H), 6.80 (s, 1H), 6.60 (d, J = 7.7 Hz, 1H), 
4.11 (m, 2H), 3.62 (s, 1H), 3.50 (pentet, J = 8.4 Hz, 1H), 2.94 (s, 2H), 2.07 (d, J = 13.3 Hz, 2H), 
1.47 (s, 9H), 1.37 (m, 2H). 
13C-NMR (175 MHz, CDCl3): δ 154.8, 147.1, 142.6, 141.7, 129.7, 128.6, 127.18, 127.16, 116.7, 
112.2, 112.1, 79.6, 50.1, 32.4, 28.4.  
IR (film, cm-1): 3366, 2974, 2931, 2854, 1679, 1598, 1448. 
HRMS (ESI+) m/z: [M+H]+ predicted for C22H28N2O2, 353.2224; found, 353.2230. 
 
 




Following a modified general procedure B (15 mol% catalyst loading, 2.5 equiv. of amine, 4.0 
equiv. of base, at 130 °C), Ni(COD)2 (6.2 mg, 0.0225 mmol), IPrMe·HCl (20.4 mg, 0.045 mmol), 
NaO-t-Bu (57.7 mg, 0.6 mmol), 4-(3-((tert-butyldimethylsilyl)oxy)phenyl)morpholine (45.6 mg, 
0.155 mmol), and 2-methylpiperidine (44 µL, 0.375 mmol) at 130 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 90:10) to afford the 
desired product (25.0 mg, 0.096 mmol, 62% yield).  
 
1H-NMR (700 MHz, CDCl3): δ 7.15 (t, J = 7.7 Hz, 1H), 6.52 (m, 2H), 6.43 (d, J = 8.4 Hz, 1H), 
3.86 (m, 5H), 3.15 (m, 5H), 2.98 (dd, J = 10.5, 3.5 Hz, 1H), 1.86 (m, 1H), 1.74 (m, 1H), 1.64 (m, 
2H), 1.57 (m, 2H), 0.99 (d, J = 7.0 Hz, 3H).  
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13C-NMR (175 MHz, CDCl3): δ 152.6, 152.3, 129.4, 110.3, 107.5, 106.2, 67.0, 51.8, 49.7, 45.6, 
31.9, 26.2, 19.9, 14.1. 
IR (film, cm-1): 2928, 2850, 2816, 1595, 1576, 1498, 1448. 







Following a modified general procedure B (15 mol% catalyst loading, 2.5 equiv. of amine, 4.0 
equiv. of base, at 130 °C), Ni(COD)2 (6.2 mg, 0.0225 mmol), IPrMe·HCl (20.4 mg, 0.045 mmol), 
NaO-t-Bu (57.7 mg, 0.60 mmol), N-(4-((tert-butyldimethylsilyl)oxy)phenyl)acetamide (42.4 mg, 
0.160 mmol), and N-methylbutylamine (44 µL, 0.375 mmol) at 130 °C for 16 h gave a crude 
residue which was purified by flash chromatography (hexanes: ethyl acetate 90:10) to afford the 
desired product (15.2 mg, 0.069 mmol, 43% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.28 (d, J = 9.0 Hz, 2H), 7.00 (br, 1H), 6.64 (d, J = 9.0 Hz, 2H), 
3.27 (t, J = 7.5 Hz, 2H), 2.89 (s, 3H), 2.13 (s, 3H), 1.53 (pentet, J = 7.5 Hz, 2H), 1.32 (sextet, J = 
7.5 Hz, 2H), 0.93 (t, J = 7.5 Hz, 3H). 
13C-NMR (125 MHz, CDCl3): δ 168.1, 146.8, 127.9, 126.9, 122.3, 112.4, 112.0, 52.8, 38.4, 28.7, 
24.2, 20.3, 14.0 
IR (film, cm-1): 3284, 2955, 2870, 1653, 1598. 







Following a modified general procedure B (15 mol% catalyst loading, 2.5 equiv. of amine, 4.0 
equiv. of base, at 130 °C), Ni(COD)2 (12.4 mg, 0.045 mmol), IPrMe·HCl (40.8 mg, 0.09 mmol), 
NaO-t-Bu (115.6 mg, 1.20 mmol), tert-butyldimethyl((5,6,7,8-tetrahydronaphthalen-2-
yl)oxy)silane (79.7 mg, 0.300 mmol), and pyrrolidine (38 µL, 0.45 mmol) at 130 °C for 16 h gave 
a crude residue which was purified by flash chromatography (hexanes: ethyl acetate 99.5:0.5) to 
afford the desired product (44.3 mg, 0.220 mmol, 72% yield). The spectral data matches that 
previously reported in the literature.34 
 
1H-NMR (500 MHz, CDCl3): δ 6.93 (d, J = 8.0 Hz, 1H), 6.40 (dd, J = 8.5, 2.5 Hz, 1H), 6.28 (s, 










Following a modified general procedure B (15 mol% catalyst loading, 2.5 equiv. of amine, 4.0 
equiv. of base, at 130 °C), Ni(COD)2 (6.2 mg, 0.0225 mmol), IPrMe·HCl (20.4 mg, 0.045 mmol), 
NaO-t-Bu (57.7 mg, 0.60 mmol), (((8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-
decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl)bis(oxy))bis(tert-butyldimethylsilane) (75.7 
mg, 0.151 mmol), and piperidine (37 µL, 0.375 mmol) at 130 °C for 16 h gave a crude residue 
which was purified by flash chromatography (hexanes: ethyl acetate 95:5) to afford the desired 
product (65.0 mg, 0.143 mmol, 95% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.18 (d, J = 8.5 Hz, 1H), 6.77 (dd, J = 8.5, 2.5 Hz, 1H), 6.67 (d, J 
= 3.0 Hz, 1H), 3.65 (t, J = 8.5 Hz, 1H), 3.10 (t, J = 5.5 Hz, 4H), 2.82 (m, 2H), 2.28 (dd, J = 13.5, 
4.0 Hz, 1H), 2.16 (m, 1H), 1.94-1.85 (m, 3H), 1.73-1.62 (m, 5H), 1.58-1.12 (m, 10H), 0.91 (s, 
9H), 0.75 (s, 3H), 0.04 (d, J = 6.0 Hz, 6H). 
13C-NMR (125 MHz, CDCl3): δ 150.2, 137.2, 131.7, 125.9, 117.0, 114.5, 81.8, 51.0, 49.7, 44.1, 
43.6, 39.0, 37.2, 31.0, 30.0, 27.5, 26.3, 26.0, 25.9, 24.3, 23.3, 18.1, 11.4, -4.5, -4.8. 
IR (film, cm-1): 2926, 2854, 1608, 1503, 1450, 1127. 




























VI. Orthogonal Couplings 
 




Following general procedure A, 7-methoxynaphthalen-2-ol (890 mg, 5.1 mmol), imidazole (681 
mg, 10 mmol), tert-butyldimethylsilyl chloride (1.13 g, 7.5 mmol) gave a crude residue which 
was purified by flash chromatography (hexanes: ethyl acetate = 99:1) to afford the desired 
product as a clear oil (1.43 g, 4.96 mmol, 97% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.65 (t, J = 8.5 Hz, 2H), 7.11 (m, 1H), 6.99 (m, 2H), 6.93 (dt, J = 
9.0 Hz, 2.5 Hz, 1H), 3.91 (s, 3H), 1.03 (s, 9H), 0.25 (s, 6H).   
13C-NMR (125 MHz, CDCl3): δ 158.0, 154.1, 135.9, 129.1, 129.0, 124.7, 119.5, 116.5, 114.2, 
104.8, 55.2, 25.7, 18.3, -4.3. 
IR (film, cm-1): 2954, 2928, 2857, 1631, 1511. 
HRMS (ESI+) m/z: [M+H]+ predicted for  C17H24O2Si, 289.1618; found, 289.1620. 
 
 




Following general procedure B, Ni(COD)2 (4.1 mg, 0.015 mmol), IPrMe·HCl (13.6 mg, 0.03 
mmol), NaO-t-Bu (36.0 mg, 0.375 mmol), tert-butyl((7-methoxynaphthalen-2-
yl)oxy)dimethylsilane (44.2 mg, 0.153 mmol), and 1-methylpiperazine (25 µL, 0.225 mmol) at 
120 °C for 16 h gave a crude residue which was purified by flash chromatography (hexanes: 
ethyl acetate: triethylamine 75:24:1) to afford the desired product (32.2 mg, 0.125 mmol, 82% 
yield).  
 
1H-NMR (700 MHz, CDCl3): δ 7.64 (d, J = 8.4Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.12 (d, J = 9.1 
Hz, 1H), 7.05 (s, 1H), 7.02 (s, 1H), 6.95 (d, J = 9.1 Hz, 1H), 3.99 (s, 3H), 3.32 (t, J = 4.9 Hz, 
4H), 2.63 (t, J = 4.9 Hz, 4H), 2.38 (s, 3H).  
13C-NMR (175 MHz, CDCl3): δ 158.1, 149.6, 135.8, 128.9, 128.4, 123.8, 116.8, 115.8, 109.4, 
105.1, 55.2, 55.1, 49.4, 46.2.  
IR (film, cm-1): 2932, 2839, 2798, 1629, 1515, 1462. 
HRMS (ESI+) m/z: [M+H]+ predicted for  C16H20N2O, 257.1648; found, 257.1653. 
 






Following a previously published procedure,35 Ni(COD)2 (1.7 mg, 0.0062 mmol), 1,2-
bis(dicylohexylphosphino)ethane (dcype) (2.6 mg, 0.0062 mmol), 1-(7-methoxynaphthalen-2-yl)-
4-methylpiperazine (16.0 mg, 0.062 mmol), triethylaluminum (25 wt% in toluene, 34 µL), toluene 
(0.3 mL), and diisopropylether (0.3 mL) at 120 °C for 16 h gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate: triethylamine 72.5:25:2.5) to afford 
the desired product (15.0 mg, 0.059 mmol, 94% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.68 (d, J = 9.1 Hz, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.49 (s, 1H), 
7.21 (d, J = 8.4 Hz, 1H), 7.17 (d, J = 7.7 Hz, 1H), 7.09 (s, 1H), 3.32 (t, J = 4.9 Hz, 4H), 2.77 (q, J 
= 7.7 Hz, 2H), 2.64 (t, J = 4.9 Hz, 4H), 2.39 (s, 3H), 1.31 (t, J = 7.7 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ 149.2, 142.2, 134.8, 128.4, 127.3, 127.0, 124.6, 124.5, 118.6, 
110.0, 55.1, 49.5, 46.2, 29.1, 15.5.  
IR (film, cm-1): 2963, 2928, 2839, 2787, 1629, 1514.  
HRMS (ESI+) m/z: [M+H]+ predicted for  C17H22N2, 255.1856; found, 255.1856. 
 
 




Following a previously published procedure,35 Ni(COD)2 (4.1 mg, 0.015 mmol), 1,2-
bis(dicylohexylphosphino)ethane (dcype) (6.3 mg, 0.015 mmol), tert-butyl((7-
methoxynaphthalen-2-yl)oxy)dimethylsilane (43.2 mg, 0.150 mmol), triethylaluminum (25 wt% in 
toluene, 161 µL), toluene (0.3 mL), and diisopropylether (0.3 mL) at 120 °C for 16 h gave a 
crude residue which was purified by flash chromatography (hexanes) to afford the desired 
product (29.2 mg, 0.102 mmol, 68% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.69 (m, 2H), 7.49 (s, 1H), 7.21 (dd, J = 8.5, 2.0 Hz, 1H), 7.15 (d, 
J = 2.0 Hz, 7.02 (dd, J = 9.0, 2.5 Hz, 1H), 2.79 (q, J = 8.0 Hz, 2H), 1.33 (t, J = 8.0 Hz, 3H), 1.03 
(s, 9H), 0.25 (s, 6H).  
13C-NMR (125 MHz, CDCl3): δ 153.5, 142.1, 134.9, 129.0, 127.7, 127.5, 125.0, 124.4, 121.2, 
114.6, 29.0, 25.7, 18.3, 15.5, -4.3.   
IR (film, cm-1): 2958, 2929, 2857, 1632, 1606, 1511, 1461. 
HRMS (ESI+) m/z: [M+H]+ predicted for C18H26OSi, 287.1826; found, 287.1829. 
 
 






Following general procedure B, Ni(COD)2 (3.0 mg, 0.011 mmol), IPrMe·HCl (9.80 mg, 0.022 
mmol), NaO-t-Bu (25.9 mg, 0.270 mmol), tert-butyl((7-ethylnaphthalen-2-yl)oxy)dimethylsilane 
(31.0 mg, 0.108 mmol), and 1-methylpiperazine (18 µL, 0.162 mmol) at 120 °C for 16 h gave a 
crude residue which was purified by flash chromatography (hexanes: ethyl acetate:triethylamine 
72.5:25:2.5) to afford the desired product (26.8 mg, 0.105 mmol, 97% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.68 (d, J = 9.1 Hz, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.49 (s, 1H), 
7.21 (d, J = 8.4 Hz, 1H), 7.17 (d, J = 7.7 Hz, 1H), 7.09 (s, 1H), 3.32 (t, J = 4.9 Hz, 4H), 2.77 (q, J 
= 7.7 Hz, 2H), 2.64 (t, J = 4.9 Hz, 4H), 2.39 (s, 3H), 1.31 (t, J = 7.7 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ 149.2, 142.2, 134.8, 128.4, 127.3, 127.0, 124.6, 124.5, 118.6, 
110.0, 55.1, 49.5, 46.2, 29.1, 15.5.  
IR (film, cm-1): 2963, 2928, 2839, 2787, 1629, 1514.  













































Following a previously published procedure17, 6-bromonaphthalen-2-ol (2.2 g, 9.86 mmol), 
K2CO3 (2.76 g, 10 mmol), methyl iodide (1.25 mL, 20 mmol), and DMF (10 mL) gave a crude 
residue which was purified by flash chromatography (hexanes) to afford the desired product as 
a white solid (2.065 g, 8.71 mmol, 88% yield). 
 
1H-NMR (700 MHz, CDCl3): δ 7.92 (s, 1H), 7.65 (d, J = 9.0 Hz, 1H), 7.61 (d, J = 8.6 Hz, 1H), 
7.50 (d, J = 8.8 Hz, 1H), 7.17 (d, J = 9.0 Hz, 1H), 7.10 (s, 1H), 3.92 (s, 3H). 
13C-NMR (175 MHz, CDCl3): δ 157.9, 133.0, 130.0, 129.64, 129.60, 128.5, 128.4, 119.8, 117.0, 
105.7, 55.3.    
IR (film, cm-1): 3061, 2966, 2840, 1625, 1584, 1498.  







Following a previously published procedure8, 2-bromo-6-methoxynaphthalene (36.2 mg, 0.153 
mmol), (4-((tert-butyldimethylsilyl)oxy)-2-chlorophenyl)boronic acid (64.5 mg, 0.225 mmol), 
K3PO4 ( 191 mg, 0.9 mmol), PdCl2(PPh3)2 (5.3 mg, 0.0075 mmol), toluene (0.45 mL), and 
degassed H2O (0.45 mL) at 90 oC for 16 hours gave a crude residue which was purified by flash 
chromatography (hexanes: ethyl acetate = 98:2) to afford the desired product (49.7 mg, 0.125 
mmol, 82% yield). 
 
1H-NMR (700 MHz, CDCl3): δ 7.79 (s, 1H), 7.77 (m, 2H), 7.54 (d, J = 8.2 Hz, 1H), 7.29 (d, J = 
8.7 Hz, 1H), 7.18 (s, 2H), 7.00 (s, 1H), 6.83 (s, J = 8.3 Hz, 1H), 3.95 (s, 3H), 1.02 (s, 9H), 0.26 
(s, 6H).  
13C-NMR (175 MHz, CDCl3): δ 157.8, 155.4, 134.6, 133.64, 133.60, 132.8, 132.0, 129.6, 128.4, 
128.1, 126.2, 121.4, 119.0, 118.8, 105.6, 55.3, 25.6, 18.2, -4.4.    
IR (film, cm-1): 2951, 2929, 2856, 1603, 1496, 1471.  










Following a previously published procedure36, tert-butyl(3-chloro-4-(6-methoxynaphthalen-2-
yl)phenoxy)dimethylsilane (52.3 mg, 0.131 mmol), (1-propyl-1H-pyrazol-4-yl)boronic acid (23.1 
mg, 0.15 mmol), K3PO4 (45.1 mg, 0.213 mmol), Pd2dba3 (11.4 mg, 0.0125 mmol), PCy3 (3.5 mg, 
0.0125 mmol), and dioxane (0.25 mL) at 80 oC for 16 hours gave a crude residue which was 
purified by flash chromatography (hexanes: ethyl acetate 90:10) to afford the desired product 
(48.4 mg, 0.102 mmol, 78% yield). 
 
1H-NMR (700 MHz, CDCl3): δ 7.69 (m, 2H), 7.61 (d, J = 8.4 Hz, 1H), 7.38 (s, 1H), 7.25 (m, 2H), 
7.13 (m, 2H), 6.90 (s, 1H), 6.81 (d, J = 8.3 Hz, 1H), 6.74 (s, 1H), 3.93 (s, 3H), 3.84 (t, J = 6.9 
Hz, 2H), 1.67 (m, 2H), 1.04 (s, 9H), 0.72 (t, J = 7.4 Hz, 3H), 0.28 (s, 6H).  
13C-NMR (175 MHz, CDCl3): δ 157.6, 155.1, 138.5, 133.30, 133.28, 132.5, 131.9, 129.4, 128.9, 
128.5, 127.9, 126.1, 121.4, 120.3, 118.7, 118.1, 105.6, 55.3, 53.6, 25.7, 23.6, 18.2, 10.9, -4.3.  
IR (film, cm-1): 2956, 2929, 2857, 1605, 1496. 








Following a previously published procedure35, 4-(5-((tert-butyldimethylsilyl)oxy)-2-(6-
methoxynaphthalen-2-yl)phenyl)-1-propyl-1H-pyrazole (33.0 mg, 0.070 mmol), Ni(COD)2 (1.9 
mg, 0.007 mmol), 1,2-bis(dicylohexylphosphino)ethane (dcype) (3.0 mg, 0.007 mmol),  
triethylaluminum (25 wt% in toluene, 75 µL), toluene (0.14 mL), and diisopropylether (0.14 mL) 
at 120 °C for 16 h gave a crude residue which was purified by flash chromatography (hexanes: 
ethyl acetate 90:10) to afford the desired product (31.0 mg, 0.066 mmol, 94% yield).  
 
1H-NMR (700 MHz, CDCl3): δ 7.72 (t, J = 4.0 Hz, 2H), 7.64 (d, J = 8.4 Hz, 1H), 7.60 (s, 1H), 
7.38 (s, 1H), 7.35 (d, J = 8.3 Hz, 1H), 7.25 (m, 2H), 6.99 (s, 1H), 6.81 (d, J = 8.3 Hz, 1H), 6.74 
(s, 1H), 3.84 (t, J = 7.0 Hz, 2H), 2.82 (q, J = 7.6 Hz, 2H), 1.66 (sextet, J = 7.2 Hz, 2H), 1.34 (t, J 
= 7.6 Hz, 3H), 1.04 (s, 9H), 0.72 (t, J = 7.7 Hz), 3H), 0.28 (s, 6H).  
13C-NMR (175 MHz, CDCl3): δ 155.1, 141.7, 138.8, 138.5, 133.3, 132.5, 132.4, 132.0, 131.9, 
128.5, 127.83, 127.77, 127.2, 126.7, 125.3, 121.4, 120.3, 118.1, 53.6, 29.0, 25.7, 23.6, 18.2, 
15.5, 10.9, -4.3.  
IR (film, cm-1): 2959, 2929, 2857, 1602, 1495, 1472. 









Following general procedure B, 4-(5-((tert-butyldimethylsilyl)oxy)-2-(6-ethylnaphthalen-2-
yl)phenyl)-1-propyl-1H-pyrazole (42.8 mg, 0.091 mmol), Ni(COD)2 (2.5 mg, 0.0091 mmol), 
IPrMe·HCl (8.2 mg, 0.0182 mmol), NaO-t-Bu (21.9 mg, 0.228 mmol), and N-methylbutylamine 
(16.2 µL, 0.136 mmol) at 120 °C for 16 h gave a crude residue which was purified by flash 
chromatography (hexanes: ethyl acetate 90:10) to afford the desired product (29.0 mg, 0.068 
mmol, 75% yield).  
 
1H-NMR (500 MHz, CDCl3): δ 7.71 (m, 2H), 7.59 (m, 2H), 7.46 (s, 1H), 7.32 (d, J = 8.5 Hz, 1H), 
7.29 (d, J = 8.5 Hz, 1H), 7.24 (d, J = 8.5 Hz, 1H), 6.79 (d, J = 2.5 Hz, 1H), 6.76 (s, 1H), 6.71 (dd, 
J = 8.5, 2.5 Hz, 1H), 3.85 (t, J = 7.0 Hz, 2H), 3.39 (t, J = 7.0 Hz, 2H), 3.01 (s, 3H), 2.81 (q, J = 
7.0 Hz, 2H), 1.65 (m, 4H), 1.41 (sextet, J = 7.0 Hz, 2H), 1.33 (t, J = 7.5 Hz, 3H), 0.98 (t, J = 7.0 
Hz, 3H), 0.72 (t, J = 7.0 Hz, 3H).  
13C-NMR (125 MHz, CDCl3): δ 148.8, 141.3, 139.2, 138.5, 132.2, 132.05, 131.99, 131.8 128.9, 
128.8, 128.0, 127.8, 127.6, 127.0, 126.5, 125.3, 122.3, 112.5, 110.7, 55.6, 52.5, 38.4, 29.02, 
29.01, 23.6, 20.4, 15.6, 14.0, 10.9.   
IR (film, cm-1): 2961, 2930, 2871, 1604, 1514, 1455. 
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